We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Simple Method Corrects Automated Hemoglobin Measurement Interference

By LabMedica International staff writers
Posted on 30 Oct 2013
Print article
Image: Normal blood sample on the left and blood sample containing high triglycerides on the right (Photo courtesy of Prof. Tisha Joy, MD).
Image: Normal blood sample on the left and blood sample containing high triglycerides on the right (Photo courtesy of Prof. Tisha Joy, MD).
Hypertriglyceridemia is a well-known factor that can interfere with the measurement of hemoglobin (HGB) using automated hematology analyzers and it can cause falsely high HGB values.

A simple but effective correction method has been introduced to rectify the interference of high blood triglyceride (TG) levels in measurement of blood HGB by automated hematology analyzers commonly used in clinical laboratories.

Clinical laboratorians at the Sichuan University (Chengdu, China) analyzed 50 whole blood samples and 50 plasma samples containing variable TG concentrations. Complete blood cell counts (CBCs) were performed by an XE-2100 automated hematology analyzer (Sysmex; Kobe, Japan) for 102 blood samples, in which high-level TG were artificially added. The same blood samples were centrifuged at different speeds to separate the plasma from blood cells. An optimal centrifugal force and time were identified to separate plasma and blood cells and to exert the least influence on the chylomicrons (CMs) in the plasma, which was then analyzed.

By using the two CBC results, a correction formula was established to calculate the corrected HGB, mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC) values. Comparisons were also made of HGB, MCH, and MCHC values before and after correction of in-patient individuals who received intralipid and developed lipemia. The percentage differences between the corrected and true values of HGB, MCH and MCHC were −0.28%, 0.06%, and −0.31%, respectively. The correlation coefficients of corrected values versus true values of HGB, MCH, and MCHC were 0.989, 0.935, and 0.717, respectively. This correction method was also effective for native lipemic samples.

The authors concluded that by adding a simple step of low-speed centrifugation, their method was able to provide reliable results of HGB, MCH, and MCHC in highly lipemic blood samples without special equipment. This provided evidence that the HGB concentration of intralipid and plasma mixture was not affected by different centrifugal conditions. Therefore, they recommended that the least time-consuming centrifugation parameter be adopted. The study was published on September 13, 2013, in the Journal of Clinical Laboratory Analysis.

Related Links:

Sichuan University
Sysmex


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TORCH Infections Test
TORCH Panel
New
Troponin I Test
Quidel Triage Troponin I Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.